跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIPAZEN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIPAZEN
Authorized
STANDARD
BIPAZEN
kvr pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7895f975fa99e2b2
Company
kvr pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
7895f975fa99e2b2
Drug Approval Canada Name
BIPAZEN
Product Name
BIPAZEN
Status
Marketed
Status Date
2021-10-13
Original Market Date
2021-10-13
Din
02513579
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intravenous , Intramuscular
Schedule
Prescription
Ahfs
68:28.00
Atc Original
H01BA02 DESMOPRESSIN
Atc Name
h 01 ba 02
Aig Number
0112050006
Company Name
kvr pharmaceuticals inc.
Company Address
21 Parr Blvd, Unit 12, Caledon, Ontario, Canada, L7E 4G3
Active Ingredients
DESMOPRESSIN ACETATE
4 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7895f975fa99e2b2
Type
Standard
Back to Health Canada Approvals